APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivermectin for Human

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ivermectin for Human Industry Growth and Trends Forecast to 2032

2 January 202699 pages

Choose your research edition.

Industry ResearchIvermectin for Human Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivermectin for Human Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Ivermectin for Human Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivermectin for Human Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivermectin for Human Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Ivermectin for Human market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ivermectin for Human is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ivermectin for Human is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ivermectin for Human is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ivermectin for Human include Arbor Pharms LLC, Edenbridge Pharms, Galderma Laboratories LP, Perrigo Company plc, TARO, TEVA Pharms USA, Wellona Pharma and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ivermectin for Human market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ivermectin for Human market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ivermectin for Human market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ivermectin for Human.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ivermectin for Human market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ivermectin for Human Market by Company

Arbor Pharms LLC

Edenbridge Pharms

Galderma Laboratories LP

Perrigo Company plc

TARO

TEVA Pharms USA

Wellona Pharma

Merck

Ivermectin for Human Segment by Type

Injection

Oral

Topical (Cream and Lotion)

Ivermectin for Human Segment by Application

For Onchocerciasis Treatment

For Headlice Treatment

Others

Ivermectin for Human Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivermectin for Human market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivermectin for Human and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivermectin for Human.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ivermectin for Human manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ivermectin for Human in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Oral Table 3. Major Company of Topical (Cream and Lotion) Table 4. Global Ivermectin for Human Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 6. Global Ivermectin for Human Sales Market Share in Volume by Type (2021-2026) Table 7. Global Ivermectin for Human Sales by Type (2021-2026) & (US$ Million) Table 8. Global Ivermectin for Human Sales Market Share in Value by Type (2021-2026) Table 9. Global Ivermectin for Human Price by Type (2021-2026) & (US$/Kg) Table 10. Global Ivermectin for Human Sales by Type (2027-2032) & (Kg) Table 11. Global Ivermectin for Human Sales Market Share in Volume by Type (2027-2032) Table 12. Global Ivermectin for Human Sales by Type (2027-2032) & (US$ Million) Table 13. Global Ivermectin for Human Sales Market Share in Value by Type (2027-2032) Table 14. Global Ivermectin for Human Price by Type (2027-2032) & (US$/Kg) Table 15. North America Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 16. North America Ivermectin for Human Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 18. Europe Ivermectin for Human Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 20. Asia-Pacific Ivermectin for Human Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 22. Latin America Ivermectin for Human Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Ivermectin for Human Sales by Type (2021-2026) & (Kg) Table 24. Middle East and Africa Ivermectin for Human Sales by Type (2021-2026) & (US$ Million) Table 25. Ivermectin for Human Industry Trends Table 26. Ivermectin for Human Industry Drivers Table 27. Ivermectin for Human Industry Opportunities and Challenges Table 28. Ivermectin for Human Industry Restraints Table 29. Global Ivermectin for Human Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Ivermectin for Human Revenue Market Share by Company (2021-2026) Table 31. Global Ivermectin for Human Sales by Company (2021-2026) & (Kg) Table 32. Global Ivermectin for Human Sales Share by Company (2021-2026) Table 33. Global Ivermectin for Human Market Price by Company (2021-2026) & (US$/Kg) Table 34. Global Ivermectin for Human Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Ivermectin for Human Major Company Production Sites and Headquarters Table 36. Global Ivermectin for Human Company, Product Type & Application Table 37. Global Ivermectin for Human Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Ivermectin for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Ivermectin for Human Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Ivermectin for Human Sales by Region (2021-2026) & (Kg) Table 42. Global Ivermectin for Human Sales Market Share in Volume by Region (2021-2026) Table 43. Global Ivermectin for Human Sales by Region (2021-2026) & (US$ Million) Table 44. Global Ivermectin for Human Sales Market Share in Value by Region (2021-2026) Table 45. Global Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Global Ivermectin for Human Sales by Region (2027-2032) & (Kg) Table 47. Global Ivermectin for Human Sales Market Share in Volume by Region (2027-2032) Table 48. Global Ivermectin for Human Sales by Region (2027-2032) & (US$ Million) Table 49. Global Ivermectin for Human Sales Market Share in Value by Region (2027-2032) Table 50. Global Ivermectin for Human Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 51. Global Ivermectin for Human Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 53. Global Ivermectin for Human Sales Market Share in Volume by Application (2021-2026) Table 54. Global Ivermectin for Human Sales by Application (2021-2026) & (US$ Million) Table 55. Global Ivermectin for Human Sales Market Share in Value by Application (2021-2026) Table 56. Global Ivermectin for Human Price by Application (2021-2026) & (US$/Kg) Table 57. Global Ivermectin for Human Sales by Application (2027-2032) & (Kg) Table 58. Global Ivermectin for Human Sales Market Share in Volume by Application (2027-2032) Table 59. Global Ivermectin for Human Sales by Application (2027-2032) & (US$ Million) Table 60. Global Ivermectin for Human Sales Market Share in Value by Application (2027-2032) Table 61. Global Ivermectin for Human Price by Application (2027-2032) & (US$/Kg) Table 62. North America Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 63. North America Ivermectin for Human Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 65. Europe Ivermectin for Human Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 67. Asia-Pacific Ivermectin for Human Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 69. Latin America Ivermectin for Human Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Ivermectin for Human Sales by Application (2021-2026) & (Kg) Table 71. Middle East and Africa Ivermectin for Human Sales by Application (2021-2026) & (US$ Million) Table 72. Arbor Pharms LLC Company Information Table 73. Arbor Pharms LLC Business Overview Table 74. Arbor Pharms LLC Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Arbor Pharms LLC Ivermectin for Human Product Portfolio Table 76. Arbor Pharms LLC Recent Development Table 77. Edenbridge Pharms Company Information Table 78. Edenbridge Pharms Business Overview Table 79. Edenbridge Pharms Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Edenbridge Pharms Ivermectin for Human Product Portfolio Table 81. Edenbridge Pharms Recent Development Table 82. Galderma Laboratories LP Company Information Table 83. Galderma Laboratories LP Business Overview Table 84. Galderma Laboratories LP Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. Galderma Laboratories LP Ivermectin for Human Product Portfolio Table 86. Galderma Laboratories LP Recent Development Table 87. Perrigo Company plc Company Information Table 88. Perrigo Company plc Business Overview Table 89. Perrigo Company plc Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Perrigo Company plc Ivermectin for Human Product Portfolio Table 91. Perrigo Company plc Recent Development Table 92. TARO Company Information Table 93. TARO Business Overview Table 94. TARO Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. TARO Ivermectin for Human Product Portfolio Table 96. TARO Recent Development Table 97. TEVA Pharms USA Company Information Table 98. TEVA Pharms USA Business Overview Table 99. TEVA Pharms USA Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. TEVA Pharms USA Ivermectin for Human Product Portfolio Table 101. TEVA Pharms USA Recent Development Table 102. Wellona Pharma Company Information Table 103. Wellona Pharma Business Overview Table 104. Wellona Pharma Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Wellona Pharma Ivermectin for Human Product Portfolio Table 106. Wellona Pharma Recent Development Table 107. Merck Company Information Table 108. Merck Business Overview Table 109. Merck Ivermectin for Human Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Merck Ivermectin for Human Product Portfolio Table 111. Merck Recent Development Table 112. North America Ivermectin for Human Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 113. North America Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 114. North America Ivermectin for Human Sales Market Share by Country (2021-2026) Table 115. North America Ivermectin for Human Sales Forecast by Country (2027-2032) & (Kg) Table 116. North America Ivermectin for Human Sales Market Share Forecast by Country (2027-2032) Table 117. North America Ivermectin for Human Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Ivermectin for Human Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Ivermectin for Human Market Share by Country (2021-2026) Table 120. North America Ivermectin for Human Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Ivermectin for Human Market Share Forecast by Country (2027-2032) Table 122. Europe Ivermectin for Human Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 123. Europe Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 124. Europe Ivermectin for Human Sales Market Share by Country (2021-2026) Table 125. Europe Ivermectin for Human Sales Forecast by Country (2027-2032) & (Kg) Table 126. Europe Ivermectin for Human Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Ivermectin for Human Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Ivermectin for Human Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Ivermectin for Human Market Share by Country (2021-2026) Table 130. Europe Ivermectin for Human Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Ivermectin for Human Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Ivermectin for Human Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 134. Asia-Pacific Ivermectin for Human Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Ivermectin for Human Sales Forecast by Country (2027-2032) & (Kg) Table 136. Asia-Pacific Ivermectin for Human Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Ivermectin for Human Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Ivermectin for Human Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Ivermectin for Human Market Share by Country (2021-2026) Table 140. Asia-Pacific Ivermectin for Human Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Ivermectin for Human Market Share Forecast by Country (2027-2032) Table 142. Latin America Ivermectin for Human Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 143. Latin America Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 144. Latin America Ivermectin for Human Sales Market Share by Country (2021-2026) Table 145. Latin America Ivermectin for Human Sales Forecast by Country (2027-2032) & (Kg) Table 146. Latin America Ivermectin for Human Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Ivermectin for Human Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Ivermectin for Human Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Ivermectin for Human Market Share by Country (2021-2026) Table 150. Latin America Ivermectin for Human Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Ivermectin for Human Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Ivermectin for Human Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Ivermectin for Human Sales by Country (2021-2026) & (Kg) Table 154. Middle East and Africa Ivermectin for Human Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Ivermectin for Human Sales Forecast by Country (2027-2032) & (Kg) Table 156. Middle East and Africa Ivermectin for Human Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Ivermectin for Human Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Ivermectin for Human Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Ivermectin for Human Market Share by Country (2021-2026) Table 160. Middle East and Africa Ivermectin for Human Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Ivermectin for Human Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Ivermectin for Human Distributors List Table 165. Ivermectin for Human Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Ivermectin for Human Image Figure 2. Global Ivermectin for Human Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivermectin for Human Market Size (2021-2032) & (US$ Million) Figure 4. Global Ivermectin for Human Sales (2021-2032) & (Kg) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (Kg) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (Kg) Figure 9. Topical (Cream and Lotion) Image Figure 10. Global Topical (Cream and Lotion) Sales YoY Growth (2021-2032) & (Kg) Figure 11. Global Ivermectin for Human Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Ivermectin for Human Market Share by Type 2025 VS 2032 Figure 13. North America Ivermectin for Human Sales Market Share in Volume by Type in 2025 Figure 14. North America Ivermectin for Human Sales Market Share in Value by Type in 2025 Figure 15. Europe Ivermectin for Human Sales Market Share in Volume by Type in 2025 Figure 16. Europe Ivermectin for Human Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Ivermectin for Human Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Ivermectin for Human Sales Market Share in Value by Type in 2025 Figure 19. Latin America Ivermectin for Human Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Ivermectin for Human Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Ivermectin for Human Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Ivermectin for Human Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Ivermectin for Human Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. For Onchocerciasis Treatment Image Figure 26. Global For Onchocerciasis Treatment Sales YoY Growth (2021-2032) & (Kg) Figure 27. For Headlice Treatment Image Figure 28. Global For Headlice Treatment Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Ivermectin for Human Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Ivermectin for Human Market Share by Application 2025 VS 2032 Figure 33. North America Ivermectin for Human Sales Market Share in Volume by Application in 2025 Figure 34. North America Ivermectin for Human Sales Market Share in Value by Application in 2025 Figure 35. Europe Ivermectin for Human Sales Market Share in Volume by Application in 2025 Figure 36. Europe Ivermectin for Human Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Ivermectin for Human Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Ivermectin for Human Sales Market Share in Value by Application in 2025 Figure 39. Latin America Ivermectin for Human Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Ivermectin for Human Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Ivermectin for Human Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Ivermectin for Human Sales Market Share in Value by Application in 2025 Figure 43. North America Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Ivermectin for Human Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Ivermectin for Human Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Ivermectin for Human Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Ivermectin for Human Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ivermectin for Human Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Ivermectin for Human Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Ivermectin for Human Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ivermectin for Human Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Ivermectin for Human Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Ivermectin for Human Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ivermectin for Human Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Ivermectin for Human Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Ivermectin for Human Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Ivermectin for Human Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ivermectin for Human Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Ivermectin for Human Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Ivermectin for Human Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Ivermectin for Human Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
  • Topical (Cream and Lotion)
Applications
  • For Onchocerciasis Treatment
  • For Headlice Treatment
  • Others
Companies covered
  • Arbor Pharms LLC
  • Edenbridge Pharms
  • Galderma Laboratories LP
  • Perrigo Company plc
  • TARO
  • TEVA Pharms USA
  • Wellona Pharma
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ivermectin for Human Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ivermectin for Human Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ivermectin for Human Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Oral
  8. 1.3.3 Topical (Cream and Lotion)
  9. 1.4 Global Ivermectin for Human Market Size by Type
  10. 1.4.1 Global Ivermectin for Human Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Ivermectin for Human Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Ivermectin for Human Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Ivermectin for Human Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Ivermectin for Human Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Ivermectin for Human Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Ivermectin for Human Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Ivermectin for Human Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ivermectin for Human Industry Trends
  2. 2.2 Ivermectin for Human Industry Drivers
  3. 2.3 Ivermectin for Human Industry Opportunities and Challenges
  4. 2.4 Ivermectin for Human Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ivermectin for Human Revenue (2021-2026)
  2. 3.2 Global Top Players by Ivermectin for Human Sales (2021-2026)
  3. 3.3 Global Top Players by Ivermectin for Human Price (2021-2026)
  4. 3.4 Global Ivermectin for Human Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ivermectin for Human Major Company Production Sites & Headquarters
  6. 3.6 Global Ivermectin for Human Company, Product Type & Application
  7. 3.7 Global Ivermectin for Human Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ivermectin for Human Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ivermectin for Human Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ivermectin for Human Tier 1, Tier 2, and Tier 3
4 Ivermectin for Human Regional Status and Outlook
  1. 4.1 Global Ivermectin for Human Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ivermectin for Human Historic Market Size by Region
  3. 4.2.1 Global Ivermectin for Human Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ivermectin for Human Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ivermectin for Human Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ivermectin for Human Forecasted Market Size by Region
  7. 4.3.1 Global Ivermectin for Human Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ivermectin for Human Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ivermectin for Human Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ivermectin for Human by Application
  1. 5.1 Ivermectin for Human Market by Application
  2. 5.1.1 For Onchocerciasis Treatment
  3. 5.1.2 For Headlice Treatment
  4. 5.1.3 Others
  5. 5.2 Global Ivermectin for Human Market Size by Application
  6. 5.2.1 Global Ivermectin for Human Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ivermectin for Human Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ivermectin for Human Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ivermectin for Human Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ivermectin for Human Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ivermectin for Human Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ivermectin for Human Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ivermectin for Human Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Arbor Pharms LLC
  2. 6.1.1 Arbor Pharms LLC Company Information
  3. 6.1.2 Arbor Pharms LLC Business Overview
  4. 6.1.3 Arbor Pharms LLC Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Arbor Pharms LLC Ivermectin for Human Product Portfolio
  6. 6.1.5 Arbor Pharms LLC Recent Developments
  7. 6.2 Edenbridge Pharms
  8. 6.2.1 Edenbridge Pharms Company Information
  9. 6.2.2 Edenbridge Pharms Business Overview
  10. 6.2.3 Edenbridge Pharms Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Edenbridge Pharms Ivermectin for Human Product Portfolio
  12. 6.2.5 Edenbridge Pharms Recent Developments
  13. 6.3 Galderma Laboratories LP
  14. 6.3.1 Galderma Laboratories LP Company Information
  15. 6.3.2 Galderma Laboratories LP Business Overview
  16. 6.3.3 Galderma Laboratories LP Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Galderma Laboratories LP Ivermectin for Human Product Portfolio
  18. 6.3.5 Galderma Laboratories LP Recent Developments
  19. 6.4 Perrigo Company plc
  20. 6.4.1 Perrigo Company plc Company Information
  21. 6.4.2 Perrigo Company plc Business Overview
  22. 6.4.3 Perrigo Company plc Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Perrigo Company plc Ivermectin for Human Product Portfolio
  24. 6.4.5 Perrigo Company plc Recent Developments
  25. 6.5 TARO
  26. 6.5.1 TARO Company Information
  27. 6.5.2 TARO Business Overview
  28. 6.5.3 TARO Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 TARO Ivermectin for Human Product Portfolio
  30. 6.5.5 TARO Recent Developments
  31. 6.6 TEVA Pharms USA
  32. 6.6.1 TEVA Pharms USA Company Information
  33. 6.6.2 TEVA Pharms USA Business Overview
  34. 6.6.3 TEVA Pharms USA Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 TEVA Pharms USA Ivermectin for Human Product Portfolio
  36. 6.6.5 TEVA Pharms USA Recent Developments
  37. 6.7 Wellona Pharma
  38. 6.7.1 Wellona Pharma Company Information
  39. 6.7.2 Wellona Pharma Business Overview
  40. 6.7.3 Wellona Pharma Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wellona Pharma Ivermectin for Human Product Portfolio
  42. 6.7.5 Wellona Pharma Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Ivermectin for Human Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Ivermectin for Human Product Portfolio
  48. 6.8.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Ivermectin for Human Sales by Country
  2. 7.1.1 North America Ivermectin for Human Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ivermectin for Human Sales by Country (2021-2026)
  4. 7.1.3 North America Ivermectin for Human Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ivermectin for Human Market Size by Country
  6. 7.2.1 North America Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ivermectin for Human Market Size by Country (2021-2026)
  8. 7.2.3 North America Ivermectin for Human Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ivermectin for Human Sales by Country
  2. 8.1.1 Europe Ivermectin for Human Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ivermectin for Human Sales by Country (2021-2026)
  4. 8.1.3 Europe Ivermectin for Human Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ivermectin for Human Market Size by Country
  6. 8.2.1 Europe Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ivermectin for Human Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ivermectin for Human Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ivermectin for Human Sales by Country
  2. 9.1.1 Asia-Pacific Ivermectin for Human Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ivermectin for Human Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ivermectin for Human Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ivermectin for Human Market Size by Country
  6. 9.2.1 Asia-Pacific Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ivermectin for Human Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ivermectin for Human Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ivermectin for Human Sales by Country
  2. 10.1.1 South America Ivermectin for Human Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ivermectin for Human Sales by Country (2021-2026)
  4. 10.1.3 South America Ivermectin for Human Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ivermectin for Human Market Size by Country
  6. 10.2.1 South America Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ivermectin for Human Market Size by Country (2021-2026)
  8. 10.2.3 South America Ivermectin for Human Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ivermectin for Human Sales by Country
  2. 11.1.1 Middle East and Africa Ivermectin for Human Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ivermectin for Human Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ivermectin for Human Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ivermectin for Human Market Size by Country
  6. 11.2.1 Middle East and Africa Ivermectin for Human Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ivermectin for Human Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ivermectin for Human Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ivermectin for Human Value Chain Analysis
  2. 12.1.1 Ivermectin for Human Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ivermectin for Human Production Mode & Process
  7. 12.2 Ivermectin for Human Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ivermectin for Human Distributors
  10. 12.2.3 Ivermectin for Human Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst